There are significant gaps between what is accepted as best practice in the management of Clostridium difficile (C. diff) and what is actually happening in routine clinical care. Each year, C. diff infects roughly 500,000 people in the U.S. and often requires hospitalization. In very severe cases, C. diff infection can be deadly, with estimates of C. diff-linked death ranging from 14,000 to 30,000 each year.
Help save lives. Learn to properly diagnose and provide the correct treatment of C. diff and recurrent C. diff infection by completing AGA’s Identifying and Treating Clostridioides Difficile today.
- Identify early signs of mild to moderate C.diff based on patient risk factors and use and misuse of antibiotic therapy.
- Evaluate C.diff patients who may be at high risk of recurrence through appropriate assay analysis.
- Outline evidence-based approaches, including better antimicrobial stewardship, for initial and recurrent episodes of C.diff.
- Recommend treatment strategies for the prevention of recurrent C.diff.
You will work through six challenging cases using an interactive decision support tool based on the most recent guidelines published in 2021. Each case is handpicked by faculty to present learners with challenges you are sure to see when evaluating and treating C. diff patients.
Identifying and Treating Clostridioides Difficile is supported by an independent medical education grant from Ferring Pharmaceuticals, Inc., and offers you 1.0 AMA PRA Category 1 Credits™.
